Predict your next investment

Venture Capital
clarusventures.com

See what CB Insights has to offer

Investments

1

Funds

7

About Clarus Ventures

The firm invests in life sciences venture capital companies with biopharmaceutical and medical technology. It specializes in research and development, commercialization, business development, and operations management at the global level.

Clarus Ventures Headquarter Location

101 Main Street Suite 1210

Cambridge, Massachusetts, 02142,

United States

(617)949-2200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Clarus Ventures News

NEA Welcomes Veteran Life Sciences Investor Michele Park as Partner on Its Healthcare Investing Team

Nov 5, 2021

NEA Welcomes Veteran Life Sciences Investor Michele Park as Partner on Its Healthcare Investing Team MENLO PARK, Calif., November 4, 2021-- New Enterprise Associates, Inc. (NEA) today announced that veteran life sciences investor Michele Park has joined the firm as a Partner based in its Menlo Park office. Park joins NEA after 15 years as an investor at Clarus Ventures, where she served as a board director and member for several biopharmaceutical companies of various stages. "We are thrilled to welcome Michele to NEA and are confident that her extensive experience as a life sciences investor will be an asset to our investing team and portfolio companies alike," said Mohamad Makhzoumi, Managing General Partner, Healthcare, NEA. "We've seen firsthand through our shared investments how Michele works closely with biopharmaceutical companies across various stages, and both her scientific and company-building experience put her in a great position to be a valuable contributor to NEA's healthcare investing practice." NEA has deep roots in both the life sciences and digital health sectors with more than four decades of investing expertise across all stages, from company incubation and early-stage partnership to growth-stage and public market investment. The firm's healthcare portfolio includes renowned biopharma companies such as Tesaro and CRISPR Therapeutics, as well as leading-edge digital health companies creating new models for care delivery such as Bright Health, Everside Health, and Radiology Partners. As Partner at Clarus Ventures (now Blackstone Life Sciences), Park led the initiative to launch the Clarus Cancer Fund—a novel investment model designed to generate returns and fuel cancer research through donation. Prior to Clarus, she spent six years as a research analyst covering the biotechnology sector at Credit Suisse and Piper Jaffray. Park received her Ph.D. in Molecular Biology from the Weill Cornell Graduate School of Medical Sciences and completed her dissertation at Memorial Sloan-Kettering Cancer Center. She holds a B.A. in Molecular Biology from Princeton University. Park serves as Co-Chair of the Cancer Prevention and Research Institute of Texas (CPRIT) Product Development Advisory Committee; Board Trustee for the American Friends of the Royal Philharmonic Orchestra (AFRPO); and is a member of the Council of Korean Americans (CKA) and Private Equity Women Investor Network. About NEA New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With nearly $24 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and healthcare companies at all stages in a company's lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 230 portfolio company IPOs and more than 390 mergers and acquisitions. www.nea.com.

Clarus Ventures Investments

1 Investments

Clarus Ventures has made 1 investments. Their latest investment was in Satellite Biosciences as part of their Seed VC on November 11, 2020.

CBI Logo

Clarus Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/17/2020

Seed VC

Satellite Biosciences

$19M

Yes

1

Date

11/17/2020

Round

Seed VC

Company

Satellite Biosciences

Amount

$19M

New?

Yes

Co-Investors

Sources

1

Clarus Ventures Fund History

7 Fund Histories

Clarus Ventures has 7 funds, including Clarus IV LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/18/2017

Clarus IV LP

Multi-Stage Venture Capital

Closed

$910M

1

6/8/2015

Clarus Lifesciences III LP

Subscribe to see more

Subscribe to see more

$99M

10

9/18/2014

Clarus DE II LP

Subscribe to see more

Subscribe to see more

$99M

10

8/5/2014

Clarus Defined Exit I LP

Subscribe to see more

Subscribe to see more

$99M

10

2/25/2008

Clarus Lifesciences II LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/18/2017

6/8/2015

9/18/2014

8/5/2014

2/25/2008

Fund

Clarus IV LP

Clarus Lifesciences III LP

Clarus DE II LP

Clarus Defined Exit I LP

Clarus Lifesciences II LP

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$910M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Clarus Ventures Team

9 Team Members

Clarus Ventures has 9 team members, including current Controller, Elsa Gelin.

Name

Work History

Title

Status

Elsa Gelin

MPM Capital

Controller

Current

Dennis J Henner

MPM Capital

Managing Director

Current

Robert W Liptak

MPM Capital

Managing Director

Current

Scott Requadt

Managing Director

Current

Nicholas J Simon

MPM Capital

Managing Director

Current

Name

Elsa Gelin

Dennis J Henner

Robert W Liptak

Scott Requadt

Nicholas J Simon

Work History

MPM Capital

MPM Capital

MPM Capital

MPM Capital

Title

Controller

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.